Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
Getu Diriba, Ayinalem Alemu, Bazezew Yenew, et al.
International Journal of Infectious Diseases (2023) Vol. 132, pp. 50-63
Open Access | Times Cited: 21

Showing 21 citing articles:

Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis
Birhanu Hailu, Yitayew Demessie, Abebe Tesfaye Gessese, et al.
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access
Second-line drug resistance among multidrug-resistant tuberculosis patients in Ethiopia: A laboratory-based surveillance
Getu Diriba, Ayinalem Alemu, Bazezew Yenew, et al.
Journal of Global Antimicrobial Resistance (2025)
Open Access
In Vitro Activity of the Triazinyl Diazepine Compound FTSD2 Against Drug-Resistant Mycobacterium tuberculosis Strains
Carlos Aranaga, Rubén E. Varela, Aura Falco, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 360-360
Open Access
The critical role of new tuberculosis vaccines in achieving the WHO 2035 End TB target
Amal Al-Maani, Eskild Petersen, Ziad A. Memish
IJID Regions (2025) Vol. 14, pp. 100595-100595
Open Access
GLOBAL TRENDS, RISK FACTORS, AND CHALLENGES IN DRUG-RESISTANT TUBERCULOSIS: A SYSTEMATIC REVIEW OF ANTIMICROBIAL RESISTANCE PATTERNS AND DETERMINANTS
Ruth Chipampe Kafwanka, Rogers Chilyabanyama, Richard Chirwa, et al.
(2025)
Closed Access
Structural and biophysical characterization of PadR family protein Rv0047c of Mycobacterium tuberculosis H37Rv
Muhammad Atiqur Rah Ansari, Muhammad Zohib, Meera Kumari, et al.
Journal of Structural Biology (2025), pp. 108211-108211
Closed Access
A chitosan-modified tea tree oil self-nanoemulsion improves antibacterial effects in vivo and in vitro and promotes wound healing by influencing metabolic processes against multidrug-resistant bacterial infections
Dingyi Cai, Yan Ye, Jianye Song, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136404-136404
Closed Access | Times Cited: 2
Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study
Liang Fu, Xilin Zhang, Juan Xiong, et al.
International Journal of Infectious Diseases (2023) Vol. 135, pp. 101-108
Open Access | Times Cited: 5
Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication
Liang Fu, Wenfei Wang, Juan Xiong, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 595-604
Open Access | Times Cited: 1
Drug-resistant tuberculosis is a global cause of concern
Ole Skouvig Pedersen, Frauke Rudolf, Işık Somuncu Johansen, et al.
Ugeskrift for Læger (2024), pp. 1-8
Open Access | Times Cited: 1
Acquired Bedaquiline and Fluoroquinolones Resistance during Treatment Follow-up in Oromia Region, North Shewa, Ethiopia
Getu Diriba, Ayinalem Alemu, Betselot Zerihun Ayano, et al.
IDCases (2024) Vol. 36, pp. e01988-e01988
Open Access | Times Cited: 1
Clinical effects of detailed nursing management interventions on medication adherence and disease perception in patients with drug-resistant tuberculosis
Yanli Chen, Ya-Qin Xie, Mingyue Wei, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 20, pp. 4191-4198
Open Access | Times Cited: 1
Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis
Rubhana Raqib, Protim Sarker
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 1
Pre-extensively drug-resistant and extensively drug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis
Esteban A. Alarcón‐Braga, Farley E. Salazar-Valdivia, Jose M. Estrada-Grossmann, et al.
American Journal of Infection Control (2023) Vol. 52, Iss. 3, pp. 349-357
Closed Access | Times Cited: 1
AMR: An Emerging Threat
Sayan Bhattacharyya
Public Health Open Access (2024) Vol. 8, Iss. 1, pp. 1-5
Open Access
RECENT PHARMACOLOGICAL ADVANCES IN THE TREATMENT OF TUBERCULOSIS: AN UPDATED NARRATIVE BIBLIOGRAPHICAL REVIEW
Camila Agostinis Silva, Gabriella Montandon Lassi Nunes, Erica Prevital Nery, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 12, pp. 2-12
Open Access
Respiratory fluoroquinolones in the treatment of specific and non-specific lung diseases (literature review)
E. Yakovleva, E. P. Еremenko, Е. А. Бородулина
Vrach (2024) Vol. 35, Iss. 2, pp. 20-24
Closed Access
Evaluation of Diagnostic Methods and Rifampicin Resistance in Pulmonary Tuberculosis: A Hospital-Based Study
Priyanka Joshi, Krishna G Singh, Vishal Patidar, et al.
Cureus (2024)
Open Access
Activity of clofazimine against clinical isolates of <i>Mycobacterium tuberculosis</i> with different spectrum of drug resistance to anti-tuberculosis drugs
Yu. D. Mikhailova, Marina Makarova, L. Yu. Krylova, et al.
Tuberkulez i socialʹno značimye zabolevaniâ (2024) Vol. 12, Iss. 2, pp. 30-35
Open Access
Global, regional, and national burden and trends of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis in adolescents and adults aged 15-49 years from 2010 to 2021: insights from the Global Burden of Disease Study 2021
Kunping Cui, Xiaoxiao Zhao, Wei Liu, et al.
Research Square (Research Square) (2024)
Open Access
Favorable clinical outcomes and anti-mycobacterial efficacy of pretomanid in patients with highly resistant tuberculosis: A review
Tanishq Joshi, Parminder Nain, Prajwal Bhamra, et al.
Indian Journal of Tuberculosis (2023) Vol. 71, pp. S130-S135
Closed Access
Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
Liang Fu, Juan Xiong, Haibo Wang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top